ARCHIVES

White House appoints NCI Director Andrew von Eschenbach acting FDA commissioner after Lester Crawford resigns.

This article is from The Cancer Letter archive.

Vol. 31 No. 35 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

DCPC Concepts OKd Include Nurse Research Training

May 25, 1984

Funding Opportunities: NCI extends Deadline for Three RFAs

July 9, 1999

DCBD To Fund Diagnostic Clinical Trials By CCOPs, Cooperative Groups

June 30, 1989

DeVita: It Was Time To Go, and The Action Is Hot At Memorial: Says He’ll Work Well With Paul Marks

August 19, 1988

Rose Kushner, Author, Advocate, Dead At 60 Of Breast Cancer

January 19, 1990

Brandt Tells NIK There May Be No Exceptions To DRG Regulations, Maybe a Few At Comprehensive Centers

June 24, 1983